Future Health ESG Corp. filed SEC Form 8-K: Leadership Update
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State
or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS
Employer Identification No.) |
(Address of principal executive offices, including zip code)
Registrant’s telephone
number, including area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 3, 2024, the Board made several key appointments:
| · | Khairul Azmi Bin Ismaon was appointed Chief Executive Officer. |
| · | Dr. Ulf Henning Richter was appointed Chief Financial Officer. |
Effective as of June 3, 2024, the Board and the Executive Officers of the Company shall consist of solely the following persons, who shall serve until such person’s successor is elected, qualified, and appointed or until such person’s earlier resignation, removal from office, or death:
| Name | Title | ||
| Khairul Azmi Bin Ismaon | Chairman, Chief Executive Officer and Director | ||
| Dr. Ulf Henning Richter | Chief Financial Officer | ||
| Jesvin Kaur | Director | ||
| Nancy Zakhour | Independent Director | ||
| Brian David Kitney | Independent Director | ||
| Nikita Jaiswal | Independent Director |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| FUTURE HEALTH ESG CORP | |||
| By: | /s/ Khairul Azmi Bin Ismaon | ||
| Name: | Khairul Azmi Bin Ismaon | ||
| Title: | Chief Executive Officer | ||
Date: June 5, 2024 |
|||